Research Article
Identification of Biomarkers Associated with Cancerous Change in Oral Leukoplakia Based on Integrated Transcriptome Analysis
Table 2
Small-molecule drugs from the connectivity map database.
| Rank | ID | Type | Name | Description | Score |
| 1 | BRD-K57080016 | CP | Selumetinib | MEK inhibitor and MAP kinase inhibitor | −96.76 | 2 | BRD-A35519318 | CP | Benidipine | Calcium channel blocker and L-type calcium channel blocker | −95.74 | 3 | BRD-K49404994 | CP | Levetiracetam | Acetylcholine receptor agonist and N-type calcium channel blocker, synaptic vesicle glycoprotein ligand | −93.23 | 4 | BRD-A16754160 | CP | Ampicillin | Cell wall synthesis inhibitor | −92.88 | 5 | BRD-K57631554 | CP | Aminolevulinic acid | Oxidizing agent | −92.37 |
|
|
ID : broad identity; CP: compound.
|